{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:04:13Z","timestamp":1777485853063,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s40266-013-0056-1","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T09:28:57Z","timestamp":1359624537000},"page":"183-192","source":"Crossref","is-referenced-by-count":51,"title":["Benzodiazepine Use among Older Adults with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1007","volume":"30","author":[{"given":"Nicholas T.","family":"Vozoris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadas D.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea S.","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"56_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2165\/00002018-199207020-00006","volume":"7","author":"MA Cohn","year":"1992","unstructured":"Cohn MA, Morris DD, Juan D. Effects of estazolam and flurazepam on cardiopulmonary function in patients with chronic obstructive pulmonary disease. Drug Saf. 1992;7:152\u20138.","journal-title":"Drug Saf"},{"key":"56_CR2","first-page":"472","volume":"56","author":"E Jolly","year":"1996","unstructured":"Jolly E, Aguirre L, Jorge E, et al. Acute effect of lorazepam on respiratory muscles in stable patients with chronic obstructive pulmonary disease. [Article in Spanish]. Medicina (B Aires). 1996;56:472\u20138.","journal-title":"Medicina (B Aires)"},{"key":"56_CR3","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1378\/chest.97.3_Supplement.51S","volume":"97","author":"D Murciano","year":"1990","unstructured":"Murciano D, Aubier M, Palacios S, et al. Comparison of zolpidem (Z), triazolam (T), and flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD). Chest. 1990;97:51S\u20132S.","journal-title":"Chest"},{"key":"56_CR4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1183\/09031936.93.06050625","volume":"6","author":"D Murciano","year":"1993","unstructured":"Murciano D, Armengaud MH, Cramer PH, et al. Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir J. 1993;6:625\u20139.","journal-title":"Eur Respir J"},{"key":"56_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/thx.33.1.97","volume":"33","author":"M Rudolf","year":"1978","unstructured":"Rudolf M, Geddes DM, Turner JA, et al. Depression of central respiratory drive by nitrazepam. Thorax. 1978;33:97\u2013100.","journal-title":"Thorax"},{"key":"56_CR6","first-page":"230","volume":"129","author":"AJ Block","year":"1984","unstructured":"Block AJ, Dolly FR, Slayton PC. Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease? Am Rev Respir Dis. 1984;129:230\u20133.","journal-title":"Am Rev Respir Dis"},{"key":"56_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000195530","volume":"54","author":"A Beaupr\u00e9","year":"1988","unstructured":"Beaupr\u00e9 A, Soucy R, Phillips R, et al. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease. Respiration. 1988;54:235\u201340.","journal-title":"Respiration"},{"key":"56_CR8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm\/146.5_Pt_1.1256","volume":"146","author":"RB Berry","year":"1992","unstructured":"Berry RB, McCasland CR, Light RW. The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am J Respir Crit Care Med. 1992;146:1256\u2013560.","journal-title":"Am J Respir Crit Care Med"},{"key":"56_CR9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","volume":"23","author":"BR Celli","year":"2004","unstructured":"Celli BR, ATS\/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper. Eur Respir J. 2004;23:932\u201346.","journal-title":"Eur Respir J"},{"key":"56_CR10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/j.1552-4604.1989.tb03246.x","volume":"29","author":"DJ Greenblatt","year":"1989","unstructured":"Greenblatt DJ, Shader RI, Harmatz JS. Implications of altered drug disposition in the elderly: studies of benzodiazepines. J Clin Pharmacol. 1989;29:866\u201372.","journal-title":"J Clin Pharmacol"},{"key":"56_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00003088-199121030-00002","volume":"21","author":"DJ Greenblatt","year":"1991","unstructured":"Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I). Clin Pharmacokinet. 1991;21:165\u201377.","journal-title":"Clin Pharmacokinet"},{"key":"56_CR12","first-page":"1801","volume":"150","author":"RM Tamblyn","year":"1994","unstructured":"Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ. 1994;150:1801\u20139.","journal-title":"CMAJ"},{"key":"56_CR13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1046\/j.1532-5415.2001.49262.x","volume":"49","author":"K Tu","year":"2001","unstructured":"Tu K, Mamdani MM, Hux JE, et al. Progressive trends in the prevalence of benzodiazepine in older people in Ontario, Canada. J Am Geriatr Soc. 2001;49:1341\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"56_CR14","first-page":"213","volume":"8","author":"UE Busto","year":"2001","unstructured":"Busto UE, Sproule BA, Knight K, et al. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol. 2001;8:213\u201321.","journal-title":"Can J Clin Pharmacol"},{"key":"56_CR15","first-page":"72","volume":"10","author":"DB Hogan","year":"2003","unstructured":"Hogan DB, Maxwell CJ, Fung TS. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Aging and Health. Can J Clin Pharmacol. 2003;10:72\u20137.","journal-title":"Can J Clin Pharmacol"},{"key":"56_CR16","author":"AS Halme","year":"2012","unstructured":"Halme AS, Beland SG, Preville M, Tannenbaum C. Uncovering the source of new benzodiazepine prescriptions in community-dwelling older adults. Int J Geriatr Psychiatry. 2012. doi: 10.1002\/gps.3818 .","journal-title":"Int J Geriatr Psychiatry"},{"key":"56_CR17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0895-4356(96)00139-4","volume":"49","author":"GE Simon","year":"1996","unstructured":"Simon GE, VonKorff M, Barlow W, et al. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol. 1996;49:1067\u201373.","journal-title":"J Clin Epidemiol"},{"key":"56_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002280050063","volume":"50","author":"N Magrini","year":"1996","unstructured":"Magrini N, Vaccheri A, Parma E, et al. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol. 1996;50:19\u201325.","journal-title":"Eur J Clin Pharmacol"},{"key":"56_CR19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1099-1166(199904)14:4<280::AID-GPS898>3.0.CO;2-O","volume":"14","author":"M Kirby","year":"1999","unstructured":"Kirby M, Denihan A, Bruce I, et al. Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry. 1999;14:280\u20134.","journal-title":"Int J Geriatr Psychiatry"},{"key":"56_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1525-1497.1998.00074.x","volume":"13","author":"PP Gleason","year":"1998","unstructured":"Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13:243\u201350.","journal-title":"J Gen Intern Med"},{"key":"56_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002280100326","volume":"57","author":"A Fourrier","year":"2001","unstructured":"Fourrier A, Letenneur L, Dartigues JF, et al. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol. 2001;57:419\u201325.","journal-title":"Eur J Clin Pharmacol"},{"key":"56_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4088\/JCP.v63n0912","volume":"63","author":"MM Ohayon","year":"2002","unstructured":"Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychaitry. 2002;63:817\u201325.","journal-title":"J Clin Psychaitry"},{"key":"56_CR23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/thx.41.11.846","volume":"41","author":"W Cormick","year":"1986","unstructured":"Cormick W, Olson LG, Hensley MJ, et al. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax. 1986;41:846\u201354.","journal-title":"Thorax"},{"key":"56_CR24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1378\/chest.91.4.540","volume":"91","author":"ME Klink","year":"1987","unstructured":"Klink ME, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987;91:540\u20136.","journal-title":"Chest"},{"key":"56_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.105.1.151","volume":"105","author":"ME Klink","year":"1994","unstructured":"Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest. 1994;105:151\u20134.","journal-title":"Chest"},{"key":"56_CR26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1183\/09031936.00125707","volume":"31","author":"K Hill","year":"2008","unstructured":"Hill K, Geist R, Goldstein RS, et al. Anxiety and depression in end-stage COPD. Eur Resp J. 2008;31:667\u201377.","journal-title":"Eur Resp J"},{"key":"56_CR27","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1378\/chest.08-0342","volume":"134","author":"J Maurer","year":"2008","unstructured":"Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions and research needs. Chest. 2008;134:43S\u201356S.","journal-title":"Chest"},{"key":"56_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2011\/745047","volume":"18","author":"D Marciniuk","year":"2011","unstructured":"Marciniuk D, Goodridge D, Hernandez P, Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18:69\u201378.","journal-title":"Can Respir J"},{"key":"56_CR29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15412550903140865","volume":"6","author":"AS Gershon","year":"2009","unstructured":"Gershon AS, Wang C, Guan J, et al. Identifying individuals with physician diagnosed COPD in health administrative databases. J COPD. 2009;6:388\u201394.","journal-title":"J COPD"},{"key":"56_CR30","first-page":"67","volume":"10","author":"R Levy","year":"2003","unstructured":"Levy R, O\u2019Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Pharmacol. 2003;10:67\u201371.","journal-title":"Can J Pharmacol"},{"key":"56_CR31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","volume":"57","author":"GC Donaldson","year":"2002","unstructured":"Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847\u201352.","journal-title":"Thorax"},{"key":"56_CR32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128\u201338.","journal-title":"N Engl J Med"},{"key":"56_CR33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","volume":"154","author":"AF Connors Jr","year":"1996","unstructured":"Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154:959\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"56_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000067462","volume":"67","author":"M Miravitlles","year":"2000","unstructured":"Miravitlles M, Guerrero T, Mayordomo C, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration. 2000;67:495\u2013501.","journal-title":"Respiration"},{"key":"56_CR35","first-page":"1A","volume":"15S","author":"DE O\u2019Donnell","year":"2008","unstructured":"O\u2019Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20142008 update: highlights for primary care. Can Resp J. 2008;15S:1A\u20138A.","journal-title":"Can Resp J"},{"key":"56_CR36","unstructured":"Canadian Pharmacists Association. Compendium of pharmaceuticals and specialties. Ottawa: The Canadian Drug Reference for Health Professionals. Canadian Pharmacists Association; 2008."},{"key":"56_CR37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archinte.168.10.1090","volume":"168","author":"PA Rochon","year":"2008","unstructured":"Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Inter Med. 2008;168:1090\u20136.","journal-title":"Arch Inter Med"},{"key":"56_CR38","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2011. http:\/\/www.goldcopd.org ."},{"key":"56_CR39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.5665\/SLEEP.1116","volume":"34","author":"NT Vozoris","year":"2011","unstructured":"Vozoris NT, Leung RS. Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data. Sleep. 2011;34:869\u201374.","journal-title":"Sleep"},{"key":"56_CR40","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Int Med. 2009;169:1952\u201360.","journal-title":"Arch Int Med"},{"key":"56_CR41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169\u201376.","journal-title":"BMJ"},{"key":"56_CR42","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","volume":"352","author":"F Barbone","year":"1998","unstructured":"Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352:1331\u20136.","journal-title":"Lancet"},{"key":"56_CR43","doi-asserted-by":"crossref","unstructured":"The American Geriatrics Society 2012 Beers Criteria Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616\u201331.","DOI":"10.1111\/j.1532-5415.2012.03923.x"},{"key":"56_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.1997.03550010041037","volume":"278","author":"B Hemmelgarn","year":"1997","unstructured":"Hemmelgarn B, Suissa S, Huang A, et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27\u201331.","journal-title":"JAMA"},{"key":"56_CR45","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1001\/jama.1989.03430230088031","volume":"262","author":"WA Ray","year":"1989","unstructured":"Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989;262:3303\u20137.","journal-title":"JAMA"},{"key":"56_CR46","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s11606-007-0194-4","volume":"22","author":"CM Bell","year":"2007","unstructured":"Bell CM, Fischer HD, Gill SS, et al. Initiation of benzodiazepines in the elderly after hospitalization. J Gen Intern Med. 2007;22:1024\u20139.","journal-title":"J Gen Intern Med"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-013-0056-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0056-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T02:42:58Z","timestamp":1688006578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-013-0056-1"}},"subtitle":["A Population-Based Cohort Study"],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1007\/s40266-013-0056-1","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}